Cytological screening for cervical cancer in the province of Limburg, Belgium

European Journal of Cancer Prevention

Volumn 20, Issue 1, 2011, Pages 18-24

  Arbyn, Marc ^a,d   Van Nieuwenhuyse, An ^a   Bogers, Johannes ^b   De Jonge, Eric ^c   De Beeck, Lode Op ^c   Matheï, Catharina ^e   Buntinx, Frank ^c,e  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c Limburgse Kanker Stichting   (Belgium)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BELGIUM; CANCER GRADING; CANCER REGISTRY; CANCER SCREENING; CONTROLLED STUDY; CYTOLOGY; DATA BASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 78650515565     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32833ecbc6     Document Type: Article

References (25)

1. Arbyn M, Van Oyen H (2000). Cervical cancer screening in Belgium. Eur J Cancer 36:2191-2197.
2. Arbyn M, Geys H (2002). Trend of cervical cancer mortality in Belgium (1954-1994): Tentative solution for the certification problem of not specified uterine cancer. Int J Cancer 102:649-654.
3. Arbyn M, Quataert P, Van Hal G, Van Oyen H (1997). Cervical cancer screening in the Flemish Region (Belgium): Measurement of the attendance rate by telephone interview. Eur J Cancer Prev 6:389-398.
4. Arbyn M, Van Oyen H, Sartor F, Tibaldi F, Molenberghs G (2002). Description of the influence of age, period and cohort effects on cervical cancer mortality by loglinear Poisson models (Belgium, 1955-94). Arch Public Health 60:73-100.
5. Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J (2008). Liquid compared with conventional cervical cytology: A systematic review and meta-analysis. Obstet Gynecol 111:167-177.
6. Arbyn M, Benoy IH, Simoens C, Beutels P, Bogers J, Depuydt C (2009a). Prevaccination distribution of HPV types in women attending at cervical cancer screening in Belgium. Cancer Epidemiol Biomarkers Prev 20:321-330.
7. Arbyn M, Raifu AO, Bray F, Weiderpass E, Anttila A (2009b). Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 45:2640-2648.
8. Arbyn M, Rebolj M, De Kok IM, Becker N, O'Reilly M, Andrae B (2009c). The challenges for organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 45:2671-2678.
9. Arbyn M, Simoens C, Van Oyen H, Foidart J-M, Goffin F, Simon P, Fabri V (2009d). Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000). Prev Med 48:438-443.
10. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. (2010). European guidelines for quality assurance in cervical cancer screening. Second Edition-Summary Document. Ann Oncol 21:448-458.
11. Clayton D, Hills M (1995). Statistical models in epidemiology. Oxford: Oxford University Press.
12. Council of the European Union (2003). Council recommendation of 2 December 2003 on cancer screening. Off J Eur Union 878:34-38.
13. De Jonge E, Cloes E, Op DB, Adriaens B, Lousbergh D, Orye GG, Buntinx F (2008). A quasi-randomized trial on the effectiveness of an invitation letter to improve participation in a setting of opportunistic screening for cervical cancer. Eur J Cancer Prev 17:238-242.
14. De Jonge E, Op De Beeck L, Cloes E, Meekers E, Orye G, Adriaens B, et al. (2010). Ten years of cervix screening in the province of Limburg: The Likar Cytology Data (1996-2005). Tijdschr Geneeskunde 66:31-39.
15. Drijkoningen M, Bogers JP, Bourgain C, Cuvelier C, Delvenne P, Gompel C, et al. (2005). Cytopathology in Belgium. Cytopathology 16:100-104.
16. Federal Public Service for Public Health (Federale Overheidsdienst Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu/Service publique fédéral Santépublique, Sécuritéde la Chaine alimentaire et Environnement).
17. Extension of the Royal Decree on Cancer Registration with respect of cytopathology registration of acts related to early detection of cancer. Belgisch Staatsblad/Moniteur belge, 34360-34361. 2nd of June, 2010.
18. Herbert A, Bergeron C, Wiener H, Schenck U, Klinkhamer PJ, Arbyn M (2007). European guidelines for quality assurance in cervical cancer screening: Recommendations for cervical cytology terminology. Cytopathology 18:213-219.
19. IARC (2005). Cervix cancer screening. IARC handbooks of cancer prevention. Vol. 10. Lyon: IARC Press.
20. Lousbergh D, Broeders G, Cloes E, Dhollander D, Thys G, Op De Beeck L, et al. (2003). Incidence of cancer in the Belgian province of Limburg 1996-2001. LIKAR ed. Leuven: Province of Limburg.
21. Lundberg GD; National Cancer Institute (1989). The 1988 Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. JAMA 262:931-934.
22. Moss SM, Gray A, Legood R, Henstock E. Evaluation of HPV/LBC. Cervical screening pilot studies. First report to the Department of Health on evaluation of LBC (December 2002). NHS. 1-96. 2003. Institute of Cancer Research (Sutton); Institute of Health Sciences (Oxford).
23. Ronco G, Van Ballegooijen M, Becker N, Chil A, Fender M, Giubilato P, et al. (2009). Process performance of cervical screening programmes in Europe. Eur J Cancer 45:2659-2670.
24. Sasieni P, Stepniewska K, Altman D (1996). Test for trend across ordered groups revisited. Stata Tech Bull 6:193-196.
25. Van Eycken E, De Meyer L, Van de Walle G, Van Horenbeek D, Renson M (2002). Cancer incidence in Flanders 1997-1999. 1-70. D/2002/9738/I.